Waystar rises after brokerage upgrades to 'strong buy'

Waystar Holding

22/11/2024 15:35

** Shares of healthcare payments firm Waystar  WAY.O  up
1.5% at $31.60 
    ** Raymond James upgrades stock rating to "strong buy" from
"outperform", maintains PT of $40
        ** The current valuation does not reflect the potential
durability of double-digit growth amid broader secular shifts in
healthcare to more modern technology - brokerage
  
    ** Growing healthcare complexity will only compound the
regulatory and administrative burden on providers, which we
think will disproportionally benefit vertical SaaS players with
a suite sale - Raymond James
        ** Avg. rating of 10 brokerages for the stock is a
"buy"; the median PT is $36, according to data compiled by LSEG
  
    ** As of last close, shares up 44.8% from WAY's June IPO
price of $21.50 
    

 (Reporting by Sukriti Gupta in Bengaluru)
 ((Sukriti.Gupta@thomsonreuters.com;))